Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Alethia develops antibody-drug conjugate targeting KAAG1 for cancer

April 23, 2014

NGM-282 shows promise in early clinical and preclinical studies

April 23, 2014

Novel cancer vaccine combined with cyclophosphamide shows potential in a phase I trial

April 23, 2014

Novel PI3K-p110beta/delta inhibitor demonstrates potent antitumor efficacy in vivo

April 23, 2014

CRLX-522 leads to reduction of tumor growth in vivo

April 23, 2014

Safety, immunogenicity and efficacy of DCVAC/PCa vaccine in recurrent prostate cancer

April 23, 2014

Adamed presents a novel bioconjugate for tumor-targeted drug delivery

April 22, 2014

Cyclophilin inhibitor NVP-018 inhibits HBV preclinically

April 22, 2014

Researchers present further clinical data for Liproca depot

April 22, 2014

Novel miRNA biomarkers for predicting response to cardiac procedures

April 22, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...